Clinical Trial Update: A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS [Phase 3]

View source ↗

Summary

This completed Phase 3 randomized trial evaluated intravenous ganciclovir for peripheral cytomegalovirus retinitis in patients with AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Retinitis
• HIV Infection

Drugs mentioned

• Cytovene (ganciclovir)
• GANCICLOVIR (GANCICLOVIR SODIUM)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Retinitis, HIV Infections | Phase 3 | Status: COMPLETED